A new report by the Institute for Scientific Information on Coffee assesses the latest research into the potential role of coffee consumption in reducing risk of cardiovascular disease.
Summer 2022 sees a much-desired return of some incredible sporting events after the pandemic. To support this, the Institute for Scientific Information on Coffee (ISIC) has reviewed the latest research on the impact that coffee, through its bioactive compounds such as caffeine, may have on participants’ performance.
3-4 cups of coffee per day is associated with an approximate 25% lower risk of developing type 2 diabetes.
Coffee can used as an ergogenic aid and can improve performance in endurance cycling and running.
2-3 cups of coffee daily is associated with a 10-15% reduced risk of developing coronary heart disease, heart failure or a heart rhythm problem.
Drinking coffee can stimulate digestion as well as reducing risk of gallstones and certain liver diseases, such as pancreatitis.
Millions of people around the world enjoy a cup of coffee, whether at home, whilst on the move or at work. Coffee is one of the most researched ingredients; resulting in the publication of hundreds of scientific studies every year. In 2003, the Institute for Scientific Information on Coffee (ISIC) identified a strategic need to become more proactive in informing medical and healthcare professionals and specialist medical media about current scientific knowledge and understanding on coffee consumption and health.
Research among healthcare professionals across Europe identified a widely spread lack of current knowledge about the health effects of coffee and many misconceptions among doctors, nurses, dietitians and other healthcare professionals who, in turn, provide advice to patients and clients about the effects of drinking coffee on health. ISIC’s communications are based on sound science and rely on evidence and scientific studies derived from peer-reviewed scientific journals and other publications.